Chengdu Bright Eye Hospital Group (SZSE:301239) Is Reinvesting At Lower Rates Of Return

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key financial metrics. Typically, we'll want to notice a trend of growing return on capital employed (ROCE) and alongside that, an expanding base of capital employed. This shows us that it's a compounding machine, able to continually reinvest its earnings back into the business and generate higher returns. In light of that, when we looked at Chengdu Bright Eye Hospital Group (SZSE:301239) and its ROCE trend, we weren't exactly thrilled.

What Is Return On Capital Employed (ROCE)?

Just to clarify if you're unsure, ROCE is a metric for evaluating how much pre-tax income (in percentage terms) a company earns on the capital invested in its business. Analysts use this formula to calculate it for Chengdu Bright Eye Hospital Group:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

0.036 = CN¥139m ÷ (CN¥4.7b - CN¥785m) (Based on the trailing twelve months to September 2024).

Thus, Chengdu Bright Eye Hospital Group has an ROCE of 3.6%. In absolute terms, that's a low return and it also under-performs the Healthcare industry average of 9.0%.

View our latest analysis for Chengdu Bright Eye Hospital Group

In the above chart we have measured Chengdu Bright Eye Hospital Group's prior ROCE against its prior performance, but the future is arguably more important. If you're interested, you can view the analysts predictions in our free analyst report for Chengdu Bright Eye Hospital Group .

How Are Returns Trending?

On the surface, the trend of ROCE at Chengdu Bright Eye Hospital Group doesn't inspire confidence. Over the last five years, returns on capital have decreased to 3.6% from 13% five years ago. Meanwhile, the business is utilizing more capital but this hasn't moved the needle much in terms of sales in the past 12 months, so this could reflect longer term investments. It's worth keeping an eye on the company's earnings from here on to see if these investments do end up contributing to the bottom line.

The Bottom Line On Chengdu Bright Eye Hospital Group's ROCE

To conclude, we've found that Chengdu Bright Eye Hospital Group is reinvesting in the business, but returns have been falling. And in the last year, the stock has given away 20% so the market doesn't look too hopeful on these trends strengthening any time soon. In any case, the stock doesn't have these traits of a multi-bagger discussed above, so if that's what you're looking for, we think you'd have more luck elsewhere.

One more thing to note, we've identified 1 warning sign with Chengdu Bright Eye Hospital Group and understanding this should be part of your investment process.

While Chengdu Bright Eye Hospital Group may not currently earn the highest returns, we've compiled a list of companies that currently earn more than 25% return on equity. Check out this free list here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.